Regulatory Story
Go to market news section View chart   Print
Blinkx Plc  -  BLNX   

Director/PDMR Shareholding

Released 13:00 30-Nov-2012

RNS Number : 4551S
Blinkx Plc
30 November 2012

blinkx plc


(the 'Company')


Directors' Dealings


blinkx plc announces that on 29 November 2012 Dr. Michael R Lynch, a Non-Executive Director, notified the Company that he had exercised options over 35,248 blinkx plc Ordinary Shares ('blinkx Shares') at an exercise price of £0.45 per share, and subsequently sold those blinkx Shares at a price of £0.6875 per share on 28 November 2012

These share options were granted under the blinkx Autonomy Employee Discretionary Share Option Scheme 2007 by virtue of Dr Lynch's employment with Autonomy, and were scheduled to lapse if not exercised. Following this transaction, Dr Lynch has no share options in the Company. Dr. Lynch has an interest in 21,902,712 blinkx Shares, representing 6.0% of the Company's issued share capital.

For further information please contact:

Capita Company Secretarial Services

+44 (0) 207 954 9543


Charles Lytle

Christopher Wren

Citigroup Global Markets Ltd

NOMAD and Broker for blinkx

+44 (0)207 986 9756

This information is provided by RNS
The company news service from the London Stock Exchange

London Stock Exchange plc is not responsible for and does not check content on this Website. Website users are responsible for checking content. Any news item (including any prospectus) which is addressed solely to the persons and countries specified therein should not be relied upon other than by such persons and/or outside the specified countries. Terms and conditions, including restrictions on use and distribution apply.


Director/PDMR Shareholding - RNS